Sharecafe

Radiopharm Theranostics: Developing a portfolio of assets targeting cancer

Radiopharm Theranostics Limited CEO and Managing Director Riccardo Canevari provides an update on the company's pipeline and discusses the recent licensing of an asset from UCLA.

Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari provides an update on the company’s pipeline and discusses the recent licensing of an asset from UCLA.

Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X

All Categories